Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOGAM 1000 in Atopic Dermatitis
NCT00878670Phase 4Completed
- Sponsor
- Max Zeller Söhne
- Start
- Mar 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of evening primrose oil in atopic dermatitis (AD), sponsored by Max Zeller Söhne. Started Mar 2009; status: completed.
02
Drugs
evening primrose oil
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00878670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878670.